Table 5.

Univariate and multivariate COX proportional risk regression model analysis of the occurrence of adverse clinical outcome events in AVF patients (n = 135).

	Univariate			Multivariate
	P	HR	95%CI	P	HR	95%CI
Genders	0.57	0.86	0.53–1.44
Age of initiation of dialysis, years	<0.001	1.04	1.02–1.06	0.15	1.01	0.99–1.04
BMI, Kg/m2	0.29	1.11	0.91–1.35
Hypertension	0.07	0.49	0.22–1.07
Diabetes	0.001	2.50	1.49–4.21	0.65	1.16	0.61–2.21
Coronary artery disease	<0.001	3.21	1.98–5.20	0.09	1.73	0.93–3.33
Smoking	0.88	1.04	0.64–1.69
Drinking	0.40	1.25	0.75–2.09
LVMI (g/m2)	0.52	1.03	0.95–1.11
LVEF, %	0.50	0.99	0.96–1.02
Hemoglobin, g/L	0.03	0.56	0.33–0.96	0.52	0.81	0.43–1.53
Calcium, mmol/L	0.05	5.03	0.98–25.79
Phosphorus, mmol/L	0.54	0.88	0.58–1.33
Changes after AVF establishment
New-onset atrial fibrillation	<0.001	6.11	3.51–10.61	<0.001	4.08	2.00–8.34
left atrial enlargement	0.49	0.85	0.53–1.34
Left ventricular systolic dysfunction	0.001	2.59	1.49–4.47	0.01	2.42	1.20–4.88

BMI, Body Mass Index; LAVI, left atrial volume index; LV, left ventricle; LVEF, left ventricular ejection fraction.